As we count down to the end of 2019, we take you on a trip through some of the most popular news and innovations of the year according to you. In case you missed it – here are the top 10 stories from our Facebook page featuring Technion Researchers and Alumni!
#1 Customized Antibiotics
Customized Antibiotics are new to the scene but making waves in the industry. Technion researchers have been busy pioneering how to use them for prevention and healing!
#2. Innovation in Beauty
Color by DNA uses Technion technology to find your skin’s perfect match!
#3. Not your Granny’s Panties
Dr. Noam Gavriely’s Hemashock may look like your grandmother’s pantyhose, but it’s actually an ingenious treatment for a heart attack.
#4. The Birds and the Bees
If you want to understand, it is always best to start at the beginning! Technion’s Shai Shen-Orr talks about new immune system research.
#5. Walk a Mile in Your Own Shoes
These shoes help put a skip in your step! The smart shoes are designed with a focus on hip and knee arthroplasty rehabilitation.
#6. The 5 Minute Charge
Charging a car in the time it takes to brew a cup of coffee? Technion alumnus Doron Meyersdorf is StoreDot Ltd.’s CEO and Co-Founder. They are ready to revolutionize electric vehicles. Production will likely start in 2022.
#7. A New ADHD Treatment
InnoSphere has invented a non-invasive treatment for ADHD to replace pharmaceuticals when treating ADHD. Co-founder and VP of Engineering Yousef Badran is a Technion alumnus.
#8. Building a Home for Nemo
Could Technion Professor Ezri Tarazi and his team save the coral reef and it’s ecosystem? Discover how 3D printing is saving our planet.
#9. Nature’s Inspiration
Based on the chemical behavior of viruses and inspired by the spherical shapes found in nature, Technion researchers have developed a new system for targeted drug delivery and safer immunizations.
#10. A Magic Bullet for Fighting Cancer
Nano-ghost technology is a new and versatile drug delivery platform to fight cancer and is the only drug delivery system of its kind in the world. Nano-ghosts have proven effective in the lab and Professor Marcelle Machluf now hopes to move to human clinical trials.